Genetic Variation in IL28B and Treatment-induced Clearance of Hepatitis C Virus in HIV-Positive Patients With Acute and Chronic Hepatitis C

Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus—specific treatment in human immunodeficiency virus (HIV)—uninfected and —infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we fou...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of infectious diseases Vol. 203; no. 5; pp. 595 - 601
Main Authors Nattermann, Jacob, Vogel, Martin, Nischalke, Hans Dieter, Danta, Mark, Mauss, Stefan, Stellbrink, Hans-Jörg, Baumgarten, Axel, Mayr, Christoph, Bruno, Raffaele, Tural, Cristina, Klausen, Gerd, Clotet, Bonaventura, Naumann, Uwe, Lutz, Thomas, Rausch, Michael, Schewe, Knud, Bienek, Bernhard, Haerter, Georg, Sauerbruch, Tilman, Rockstroh, Juergen K., Spengler, Ulrich
Format Journal Article
LanguageEnglish
Published Oxford Oxford University Press 01.03.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Recently, a IL28B (rs 12979860) gene polymorphism was identified as a predictor for response to hepatits C virus—specific treatment in human immunodeficiency virus (HIV)—uninfected and —infected patients with chronic hepatitis C. In an analysis of HIV-infected patients with acute hepatitis C, we found that the IL28B genotype was associated with serum levels of hepatitis C virus RNA, g-GT, and CD4 cell count. In contrast to HIV-infected patients with chronic hepatitis C, the IL28B genotype was not significantly associated with treatment response rates in patients with acute hepatitis C. Thus, effects of the IL28B single-nucleotide polymorphism may differ in HIV-infected patients with chronic and acute hepatitis C.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Potential conflicts of interest: none reported.
Presented in part: 17th Conference on Retroviruses and Opportunistic Infections, San Francisco, February 2010 (Abstract 164).
ISSN:0022-1899
1537-6613
1537-6613
0022-1899
DOI:10.1093/infdis/jiq098